Maximum Targeted Ablation of Atrial Flutter

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2007 by Lawson Health Research Institute.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT00491010
First received: June 21, 2007
Last updated: NA
Last verified: June 2007
History: No changes posted
  Purpose

Patients undergoing atrial flutter ablation will be randomized to either the standard ablation approach or voltage targeted approach. Patients will be followed for one year to assess outcome of the ablation technique


Condition Intervention Phase
Atrial Flutter
Procedure: radiofrequency catheter ablation
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Maximum Targeted Ablation of Atrial Flutter

Further study details as provided by Lawson Health Research Institute:

Study Start Date: July 2006
Estimated Study Completion Date: February 2008
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients undergoing TV-IVC isthmus ablatin for atrial flutter

Exclusion Criteria:

  • atypical atrial flutter
  • <18 years old any atrial surgery or pacemaker refusal to participate
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00491010

Contacts
Contact: Allan Skanes, MD 519-685-8500 ext 32739 askanes@uwo.ca
Contact: Lorne gula, MD 519 685-8500 ext 32739 lgula@uwo.ca

Locations
Canada, Ontario
London Health Sciences Center Recruiting
London, Ontario, Canada, N6A 5A5
Sub-Investigator: Lorne Gula, MD         
Sponsors and Collaborators
Lawson Health Research Institute
Investigators
Principal Investigator: Allan c Skanes, MD University of Western Ontario, London Health Sciences Center
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00491010     History of Changes
Other Study ID Numbers: R-06-153, 12266
Study First Received: June 21, 2007
Last Updated: June 21, 2007
Health Authority: Canada: Ethics Review Committee

Keywords provided by Lawson Health Research Institute:
atrial flutter
ablation
voltage targeted

Additional relevant MeSH terms:
Atrial Flutter
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on August 21, 2014